Pathologic Response of Phase III Study: Perioperative Camrelizumab Plus Rivoceranib and Chemotherapy Versus Chemotherapy for Locally Advanced Gastric Cancer (DRAGON IV/CAP 05)

The SOXRC regimen significantly improved pCR compared with SOX alone in patients with G/GEJ adenocarcinoma with a tolerable safety profile.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Oncology
Published
2024-10-09
DOI
https://doi.org/10.1200/jco.24.00795
Citations
36
Primary Topic
Gastric Cancer Management and Outcomes
Type
article
Field-Weighted Citation Impact
15.08

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pathologic Response of Phase III Study: Perioperative Camrelizumab Plus Rivoceranib and Chemotherapy Versus Chemotherapy for Locally Advanced Gastric Cancer (DRAGON IV/CAP 05)

Yantao Tian, Wei Wu, Jing Zhuang, Lin Yang et al.
36 citations
Journal of Clinical Oncology
Gastric Cancer Management and Outcomes
15.08
article

Pathologic Response of Phase III Study: Perioperative Camrelizumab Plus Rivoceranib and Chemotherapy Versus Chemotherapy for Locally Advanced Gastric Cancer (DRAGON IV/CAP 05)

Yantao Tian, Wei Wu, Jing Zhuang, Lin Yang, Jianhong Dong, Dan Wu, Zhiguo Hou, Yanan Zheng, Kai Yin, Zhenqiang Wang, Lixin Jiang, Rongrong Zheng, Changhong Lian, Tao Xia, Chengxue Dang, Xixun Wang, Zhenggang Zhu, Junsheng Peng, Fei Yuan, Aimin Zhang, Hongzhi Wang, Jian Chen, Hao Chen, Chen Li, Yuting Chen, Yingwei Xue, Xi Zhao, Qian Wang, Dazhi Xu, Sanrong Xu, Heli Liu, Qun Zhao, Zhichao Zheng, Zheng Shi, Luchuan Chen, Benyan Zhang, Xiangdong Cheng, Ping Zhao, Tao Wu, Kang Wang, Bo Liang
article en
36 citations

Abstract

The SOXRC regimen significantly improved pCR compared with SOX alone in patients with G/GEJ adenocarcinoma with a tolerable safety profile.

Journal of Clinical OncologyVol. 43(4)
Hebei Medical University (CN), Jiangsu University (CN), Central South University (CN), Harbin Medical University (CN), Sun Yat-sen University (CN), Second Military Medical University (CN), Shanghai Jiao Tong University (CN), Chinese Academy of Sciences (CN), Changzhi Medical College (CN), Chinese Academy of Medical Sciences & Peking Union Medical College (CN), Ruijin Hospital (CN), Yuhuangding Hospital (CN), Fudan University Shanghai Cancer Center (CN), Sixth Affiliated Hospital of Sun Yat-sen University (CN), Zhejiang Cancer Hospital (CN), Shanxi Provincial Cancer Hospital (CN), Third Affiliated Hospital of Harbin Medical University (CN), Fourth Hospital of Hebei Medical University (CN), Affiliated Hospital of Guizhou Medical University (CN), Affiliated Hospital of Jiangsu University (CN), Changhai Hospital (CN), Sichuan Cancer Hospital (CN), First Affiliated Hospital of Xi'an Jiaotong University (CN), Lanzhou University Second Hospital (CN), Zhejiang Provincial People's Hospital (CN), Changchun 208 Hospital (CN), Affiliated Hospital of Hebei University (CN), Henan Cancer Hospital (CN), Jiangsu Hengrui Medicine (China) (CN), Fujian Provincial Cancer Hospital (CN), Tang Du Hospital (CN), Second Affiliated Hospital of Zhejiang University (CN), Hainan Medical College Hospital (CN), Xiangya Hospital Central South University (CN), Liaoning Cancer Hospital & Institute (CN), Lanzhou University (CN)
Beijing Xisike Clinical Oncology Research Foundation
Good health and well-being
Openalex Percentile: Top 1%
Gastric Cancer Management and Outcomes
15.08
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.